ACONW

ACLARION INC

• Benzinga·05/13 21:50

  Aclarion Q1 EPS $(1.34) Beats $(1.55) Estimate, Sales $21.140K Miss $25.000K Estimate

• TipRanks·05/13 02:03

  Insider Move: Aclarion Director Makes Bold New Share Purchase

• PUBT·05/12 22:54

  Aclarion director Scott Breidbart acquires 5,664 shares worth $18,012.48

• PUBT·05/12 12:31

  Aclarion director David K. Neal acquires 2,500 common shares worth $7,750

• TipRanks·05/12 02:03

  Top Executive Makes Bold Insider Move at Aclarion, Inc.

• PUBT·05/08 21:01

  Aclarion director William Wesemann acquires 1,562 common shares for $5,154.6

• Benzinga·05/07 10:09

  Aclarion Adds Lanman Spinal Neurosurgery As Clinical Site In CLARITY Trial

• Reuters·05/07 10:00

  ACLARION INC - EXPECTS PUBLIC DISCLOSURE OF EARLY INTERIM CLARITY TRIAL RESULTS IN Q4 2026

• Reuters·05/07 10:00

  ACLARION ANNOUNCES ADDITION OF FIRST PRIVATE PRACTICE SITE IN LOS ANGELES INTO CLARITY TRIAL TO FURTHER ACCELERATE ENROLLMENT

• PUBT·05/06 10:04

  Aclarion grants new Western US commercial director option for 17,000 shares at $3.2

• Dow Jones·05/06 10:00

  Press Release: Aclarion Announces Inducement Grant to New Commercial Director, Western U.S.

• NASDAQ·05/05 14:58

  Aclarion Signs Agreement With Weill Cornell For Use Of Nociscan To Treat Lumbar Disc Disease

• TipRanks·05/05 11:37

  Aclarion enters second commercial agreement with Weill Cornell Medicine

• Benzinga·05/05 10:11

  Aclarion Establishes Second Commercial Agreement With Weill Cornell Medicine; Deal Brings Nociscan To Weill Cornell Medicine And Och Spine At Newyork-Presbyterian/Weill Cornell Medical Center

• Reuters·05/05 10:08

  BRIEF-Aclarion Announces Second Commercial Agreement With Weill Cornell Medicine